Vantage Financial Partners (Illinois)’s Biogen BIIB Stock Holding History

Vantage Financial Partners (Illinois)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,950	Closed	-$579K	–	65
2019 Q4	$579K	Buy	1,950 +50	+3%	+$13.9K	0.34%	41
2019 Q3	$442K	Hold	1,900	–	–	0.29%	43
2019 Q2	$444K	Hold	1,900	–	–	0.29%	47
2019 Q1	$449K	Hold	1,900	–	–	0.3%	45
2018 Q4	$572K	Hold	1,900	–	–	0.42%	35
2018 Q3	$671K	Sell	1,900 -200	-10%	-$68.9K	0.43%	34
2018 Q2	$610K	Hold	2,100	–	–	0.4%	36
2018 Q1	$575K	Buy	2,100 +100	+5%	+$31K	0.39%	32
2017 Q4	$638K	Sell	2,000 -304	-13%	-$97.5K	0.42%	34
2017 Q3	$645K	Buy	2,304 +404	+21%	+$120K	0.45%	33
2017 Q2	$515K	Buy	+1,900	New	+$502K	0.36%	39

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vantage Financial Partners (Illinois)'s BIIB Position: Q1 2020 in Review

Vantage Financial Partners (Illinois) sold out of Biogen (BIIB) in Q1 2020, closing a stake of 1,950 shares — an estimated $579K sold.

Vantage Financial Partners (Illinois) first reported a position in BIIB in Q2 2017 and held it in 11 quarters. The position peaked at $671K in Q3 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

Vantage Financial Partners (Illinois) reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
Vantage Financial Partners (Illinois) sold 1,950 Biogen shares in Q1 2020, an estimated $579K.
Vantage Financial Partners (Illinois) first reported a position in Biogen in Q2 2017 and held it in 11 quarters.
Vantage Financial Partners (Illinois)'s Biogen position peaked at $671K in Q3 2018.
1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Vantage Financial Partners (Illinois)'s 13F filing for Q1 2020, filed 12 May 2020.